Blog
RSS FeedPosted by Michael Wonder on 18 Jan 2017
Agenda for 25 January 2017 meeting
18 January 2017 - HAS has posted the agenda for the next scheduled TC meeting. ...
Posted by Michael Wonder on 08 Jan 2017
Agenda for 11 January 2017 TC meeting
6 January 2017 - HAS has posted the agenda for the first Transparency Commission meeting for 2017. ...
Posted by Michael Wonder on 01 Dec 2016
Agenda for 7 December 2016 TC meeting
2 December 2016 - HAS has posted the agenda for the next scheduled TC meeting. ...
Posted by Michael Wonder on 25 Nov 2016
Agenda for 30 November 2016 TC meeting
24 November 2016 - HAS has posted the agenda for the next scheduled TC meeting. ...
Posted by Michael Wonder on 22 Oct 2016
France's High Authority of Health is in favour of delisting Alzheimer's disease drugs
22 October 2016 - The Transparency Committee, responsible for evaluating medicinal products within the High Authority of Health recommended against ...
Posted by Michael Wonder on 13 Oct 2016
Agenda for 19 October Transparency Commission meeting
12 October 2016 - HAS has published the agenda for the next scheduled Transparency Commission meeting. ...
Posted by Michael Wonder on 28 Sep 2016
Agenda for the 5 October 2016 TC meeting
28 September 2016 - HAS has posted the agenda for the next scheduled TC meeting. ...
Posted by Michael Wonder on 27 Sep 2016
TC opinion on Lyxumia finally published
26 September 2016 - The Transparency Commission has published its opinion on Sanofi's GLP-1 analogue. ...
Posted by Michael Wonder on 19 Sep 2016
Agenda for 21 September 2016 TC meeting
19 September 2016 - The Transparency Commission will consider the reimbursement of a number of new medicines and blood products. ...
Posted by Michael Wonder on 30 Aug 2016
Agenda for the 7 September 2016 TC meeting
30 August 2016 - The Transparency Commission will reconvene early next month after the summer break to review a few new ...
Posted by Michael Wonder on 16 Jul 2016
Agenda for the 20 July 2016 TC meeting
15 July 2016 - The Transparency Commission will consider the reimbursement of new medicines and blood products. ...
Posted by Michael Wonder on 30 Jun 2016
Agenda for the 6 July 2016 TC meeting
30 June 2016 - The Transparency Commission will consider the reimbursement of new medicines and blood products. ...
Posted by Michael Wonder on 23 Jun 2016
Agenda for the 29 June 2016 TC meeting
23 June 2016 - The Transparency Commission will consider the reimbursement of migalastat hydrochloride (Galafold), lignocaine hydrochloride with phenylephrine hydrochloride and ...
Posted by Michael Wonder on 16 Jun 2016
Agenda for the 22 June 2016 TC meeting
16 June 2016 - The Transparency Commission will consider the reimbursement of glatiramer acetate (Copaxone), ruxolitinib phosphate (Jakavi), clobazam (Likozam) and ...
Posted by Michael Wonder on 02 Jun 2016
Agenda for the 8 June 2016 TC meeting
1 June 2016 - The Transparency Commission will consider the (continued) reimbursement of dexketoprofen with tramadol hydrochloride (Skudexum), empagliflozin (Jardiance), plasma ...